WO2006101106A1 - Precious metal nanocolloid solution - Google Patents

Precious metal nanocolloid solution Download PDF

Info

Publication number
WO2006101106A1
WO2006101106A1 PCT/JP2006/305650 JP2006305650W WO2006101106A1 WO 2006101106 A1 WO2006101106 A1 WO 2006101106A1 JP 2006305650 W JP2006305650 W JP 2006305650W WO 2006101106 A1 WO2006101106 A1 WO 2006101106A1
Authority
WO
WIPO (PCT)
Prior art keywords
noble metal
solution
superoxide
platinum
gold
Prior art date
Application number
PCT/JP2006/305650
Other languages
French (fr)
Japanese (ja)
Inventor
Minenobu Okayama
Original Assignee
Apt Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apt Co., Ltd. filed Critical Apt Co., Ltd.
Priority to JP2007509289A priority Critical patent/JPWO2006101106A1/en
Publication of WO2006101106A1 publication Critical patent/WO2006101106A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/242Gold; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm

Definitions

  • the present invention relates to a noble metal nanocolloid solution containing nanoparticles of noble metals such as platinum and having high superoxide-on erasing ability.
  • a platinum nanocolloid solution containing platinum nanoparticles and a polyacrylate and having a concentration that halves superoxide-one is 200 mol Z liter or less is known (International Publication WO2005 / 023467) .
  • polyacrylic acid salt sodium or potassium salt
  • R value ratio of moles of polyacrylate converted to monomer units and moles of platinum.
  • JP-A-9-225317 discloses use of a catalyst containing nickel and a noble metal, particularly as a hydrogenation catalyst.
  • a bull polymer having a cyclic amide structure as a protective material particularly polyvinyl pyrrolidone, particularly poly N-vinyl-2-pyrrolidone, has the highest activity. It is preferred because it becomes a catalyst, and the R value (molar ratio of monomer to total metal) is 0.1 to 100, preferably 1 to 20! /.
  • alginate, starch, glycogen, gelatin, pectin, chitosan, chitin, cellulose and its derivatives, gum arabic, locust bean gum, cara gum, gum tragacanth, gati gum, agar agar, power laginin, locust bean gum , Guar gum, and xanthan gum group strength is a hydrocolloid dressing containing a selected hydrocolloid, and a sachet containing nanocrystalline platinum is known (Japanese Patent Publication No. 2004-529930).
  • hydrocolloid in this invention means a polymer (synthetically prepared or naturally occurring) that can form a thickening gel in the presence of water and a polyol (swelling agent).
  • Polymer synthetically prepared or naturally occurring
  • the swelling agent has the action of swelling the selected hydrocolloid to form a gel phase, so that it is a metal like a protective material used in the preparation of nanocolloids. It is not in a state of being coordinated with.
  • Non-patent document 1 Colloids and Surfaces B: Biointerfaces, 32, pp.117-123, 2003
  • Non-patent document 2 J. Chem. Soc, Commun., 24, 1990
  • Non-Patent Document 3 Polymer J. 3, pp. 1127-1132, 1999
  • Patent Document 1 International Publication WO2005 / 023467
  • Patent Document 2 Japanese Patent Laid-Open No. 9-225317
  • Patent Document 3 Japanese Translation of Special Publication 2004-529930 Disclosure of the invention
  • An object of the present invention is to provide a novel noble metal nanocolloid solution. More specifically, it is an object of the present invention to provide a noble metal nanocolloid solution that retains high reaction efficiency as a noble metal catalyst, has excellent intracellular uptake, and has no problems such as unpleasant odor.
  • the present inventors obtained a precious metal nanocolloid solution using a natural product-derived polysaccharide such as chitosan or bectin as a protective material. It was found that the noble metal nanocolloid solution retains high reaction efficiency as a noble metal catalyst and is excellent in cellular uptake. The inventors have found that this noble metal nanocolloid solution can be used as a superoxide-on scavenger having extremely high activity.
  • the present invention has been completed based on the above findings.
  • a superoxide-on scavenger comprising a noble metal nanocolloid solution containing noble metal nanoparticles and a natural product-derived polysaccharide.
  • the above superoxide-on erasing agent having an R value in the range of 3 to 4, the above superoxide-on erasing agent comprising two kinds of noble metals consisting of platinum and gold as noble metals
  • the above superoxide anion scavenger is provided wherein the natural product-derived polysaccharide is chitosan, pectin, or a mixture thereof.
  • a method for eliminating superoxide-one in the living body of mammals including humans in which a noble metal nanocolloid solution containing noble metal nanoparticles and a natural product-derived polysaccharide is administered to mammals including humans.
  • a method comprising the steps of:
  • the present invention provides a beverage or food containing a noble metal nanocolloid solution containing noble metal nanoparticles and a natural product-derived polysaccharide.
  • FIG. 2 is a graph showing the percentage of remaining superoxide-on when the content of gold is changed in a pectin / platinum gold nanocolloid solution.
  • FIG. 6 is a diagram showing the results of measuring the pH stability of platinum nanocolloid (PAA-Pt) using platinum nanocolloid solution (CP-PT) and polyacrylic acid of the present invention.
  • the noble metal nanocolloid solution contained in the superoxide-on scavenger of the present invention is characterized by containing noble metal nanoparticles and a natural product-derived polysaccharide.
  • the type of the noble metal is not particularly limited, and any of gold, ruthenium, rhodium, palladium, osmium, iridium, or platinum may be used, but a preferable noble metal is gold, ruthenium, rhodium, palladium, or platinum. Of these, gold or platinum is preferred. It is also preferable to use a combination of gold and platinum.
  • a noble metal nanocolloid solution containing two or more kinds of noble metals a mixture containing two or more kinds of noble metal fine particles or an alloy of two or more kinds of noble metals can be used.
  • one or more kinds of metal nanoparticles other than the noble metal may be present.
  • a natural product-derived polysaccharide having a free carboxyl group or amino group in the molecule is preferable.
  • alginic acid alginic acid, chitin 'chitosan, hyaluronic acid, pectin (including high methoxyl pectin and low methoxyl pectin, including misalignment), etc. are preferred, and low methoxyl pectin is most preferably used.
  • pectin including high methoxyl pectin and low methoxyl pectin, including misalignment
  • low methoxyl pectin is most preferably used.
  • the natural product-derived polysaccharide acts as a protective material for the noble metal nanocolloid.
  • the natural product-derived polysaccharide may be subjected to appropriate chemical modification. For example, it may be chemically modified so that it can be combined with other physiologically active substances through an appropriate spacer as required.
  • chitosan can use polysaccharides derived from natural products bound with piotin, etc. After preparing a noble metal nanocolloid solution, various bioactive substances are bound to avidin, and noble metal nanocolloid solution containing the bioactive substance is prepared. Can be prepared.
  • Pectin has a characteristic that it is soluble as much as possible, and there are no restrictions on the blending range, it has many divalent metal ions, and it is stable for a long time even in hard water, which is particularly advantageous for food applications.
  • the activity of precious metal nanocolloids that are not affected by pH is more stable than that of sodium polyacrylate that has been used in the past.
  • the particle size of the noble metal nanoparticles contained in the noble metal nanocolloid solution is not particularly limited, but nanoparticles having an average particle size of 50 nm or less can be used, preferably the average particle size is 20 nm or less, More preferably, nanoparticles having an average particle size of 10 nm or less, particularly preferably an average particle size of about 6 to 6 can be used. It is also possible to use finer nanoparticles. It is preferable that 90% or more of the noble metal nanoparticles have a particle size distribution in the range of 0.1 nm to 10 nm.
  • transition metal fine particles preferably noble metal fine particles
  • a chemical method called a precipitation method or a metal salt reduction reaction method or a physical method called a combustion method can be used.
  • the noble metal nanocolloid solution contained in the peroxide-on scavenger may contain nanoparticles prepared by any method, but it is a metal salt reduction reaction method from the viewpoint of ease of production and quality. It is preferable to use prepared nanoparticles.
  • an aqueous solution or an organic solvent solution of a water-soluble or organic solvent-soluble noble metal salt or noble metal complex is prepared, and a natural product-derived polysaccharide is added to this solution.
  • a noble metal nanocolloid solution containing noble metal nanoparticles By adjusting the pH to 9 to 11 and heating to reflux in an inert atmosphere, reduction can be performed to obtain a noble metal nanocolloid solution containing noble metal nanoparticles.
  • the type of water-soluble or organic solvent-soluble salt of the noble metal is not particularly limited, but for example, acetate, chloride, sulfate, nitrate, sulfonate, phosphate, etc. can be used.
  • a complex may be used.
  • the amount of the natural product-derived polysaccharide is not particularly limited, but is usually about 0.005 to 0.1% by weight, preferably about 0.01 to 0.025% by weight, based on the total weight of the solution.
  • various surfactants such as anionic, non-ionic, or fat-soluble surfactants may be used.
  • alcohol ethyl alcohol, n -propyl alcohol, n-butyl alcohol, n-amyl alcohol, ethylene glycol, or the like is used.
  • the method for preparing the noble metal nanoparticles is not limited to the method described above.
  • a reducing agent such as alcohol, hydrazine, sodium tetrahydroborate, or citrate is added to an aqueous solution of a noble metal salt and heated near the boiling point of the solvent, solvent reflux, ultraviolet irradiation, After the noble metal reduction reaction is combined with ultrasonic irradiation, the solvent is removed to dryness, and the resulting noble metal nanoparticles are suspended in a desired solvent to prepare a noble metal nanocolloid solution.
  • the dispersion medium is preferably substantially water-powered, but contains a small amount of an organic solvent mixed with water such as ethanol or glycerin. And!
  • the noble metal nanocolloid solution prepared by the above method may be used as it is.
  • the term “noble metal nanocolloid solution” used herein includes an aqueous dispersion in which noble metal nanoparticles are associated to form a cluster.
  • the term “nano” generally refers to the average particle size of noble metal fine particles. This means that it can be measured on the order of nanometers, but it should not be interpreted in a limited way in any way. For example, fine particles having an average particle size of about 0.01 nm are also included in the range of nanoparticles used in the present specification.
  • the use of a natural product-derived polysaccharide such as chitosan or pectin as a protective material allows the noble metal nano-particles contained in the superoxide-on scavenger of the present invention.
  • the colloidal solution has an R value of less than 80, preferably less than 40, more preferably less than 5, particularly preferably in the range of 3 to 4, which is much smaller than conventional noble metal nanocolloid solutions. (See Information Association “Synthesis of Metal Nanoparticles”, Control Technology and Application Development (published on December 22, 2004)).
  • the R value means the ratio between the number of moles of the natural product-derived polysaccharide and the number of moles of platinum converted per monomer unit).
  • the superoxide-one scavenger of the present invention is characterized in that the reactivity of the noble metal nanoparticles is extremely high and the cell accessibility is very high. In addition, the initial reaction within 1 minute is improved, and the precious metal nanocolloid solution can be efficiently prepared.
  • the superoxide-one-eliminating agent of the present invention can be administered as a pharmaceutical to mammals including humans, and can exert the superoxide-one-eliminating action in vivo.
  • the superoxide anion scavenger of the present invention can be used as a beverage having a superoxide anion erasing action, particularly as drinking water.
  • the superoxide-on-eliminating agent of the present invention is added to foods or used in the manufacture of processed foods to prepare foods containing the superoxide-on-eliminating agent of the present invention as health foods. Can also be used.
  • the superoxide-on-eliminating agent of the present invention can exert a skin beautifying effect or a whitening effect by adding it to cosmetics, or can be used for the preparation of medical devices or dental materials, or for the medium for cell culture. It can also be used for preparation.
  • Example 1 In a 100 mL eggplant flask, 2 mg of chitosan (Yaizu Suisan Chemical Co., Ltd., COS-Y, 12.4 ⁇ mol) and 19.7 mL of purified water (milli-Q) were added and stirred for 10 minutes at room temperature. hydrate solution 0.2 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) was added. After stirring at room temperature for 60 minutes, hold 0.1 mL of cooled NaBH aqueous solution (Wako Pure Chemical Industries, 0.4 M).
  • Tetrachloroethene mouthpiece acid tetrahydrate aqueous solution 0.2 mL of tetrachloroethene port chloroplatinic acid hexahydrate solution 0.2 m L (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 / z mol) was changed to the Example 1 Similarly, a chitosan / platinum nanocolloid solution was obtained.
  • Example 1 in place of the tetrachloroethene mouthpiece acid tetrahydrate aqueous solution 0.2 mL, tetrachloroethene mouthpiece acid tetrahydrate aqueous 0.1 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) and tetrachloroethene port chloroplatinic acid hexahydrate solution 0.1 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) except for using a mixture of, in the same manner as in example 1 to obtain a chitosan / platinum-gold nano colloid solution .
  • chitosan / platinum / gold nanocolloid solutions having different gold contents were prepared by using mixtures having different ratios of tetrachlorodiaurate tetrahydrate aqueous solution and tetrachlorodioctaplatinate hexahydrate aqueous solution.
  • Tetrachloroethene mouthpiece acid 4 hydrate aqueous solution 0.2 mL tetrachloroethene port chloroplatinic acid hexahydrate solution 0.2 m L in the same manner as (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol)
  • Example 4 was changed to A pectin / platinum nanocolloid solution was obtained.
  • Example 4 instead of tetrachloroethene mouthpiece acid tetrahydrate aqueous solution 0.2 mL, tetrachloroethene mouthpiece acid tetrahydrate aqueous 0.1 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) and tetrachloroethene port chloroplatinic acid hexahydrate solution 0.1 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) except for using a mixture of, in the same manner as in example 1 to obtain a chitosan / platinum-gold nano colloid solution .
  • pectin / platinum / gold nanocolloid solutions with different gold contents were prepared using mixtures having different ratios of tetrachlorodiaurate tetrahydrate aqueous solution and tetracroloplatinic acid hexahydrate aqueous solution. .
  • the superoxide-on elimination action of the noble metal nanocolloid solutions prepared in Examples 1 to 6 was investigated.
  • the hypoxanthine (HXN) / xanthine oxidase (XOD) system was used to evaluate the superoxide-on scavenging action.
  • Measurement conditions are as follows Measuring instrument: JES—FA100
  • Molecular weight marker 700 [0025] In a nanocolloid solution containing platinum and gold, the superoxide-on residual rate when the content of gold is varied is shown in Fig. 1 (chitosan / platinum / gold nanocolloid solution) and Fig. 2 ( Pectin / platinum 'gold nanocolloid solution). In any of the nanocolloid solutions, high superoxide-on erasing ability was confirmed even when the gold content was about 25 to 50%.
  • Figures 3 and 4 show the results when the amounts of chitosan and bectin were changed, respectively.
  • the maximum activity was obtained at about 0.01% by weight for chitosan and about 0.01-0.025% by weight for pectin.
  • chitosan's pyotinyi and piotiny rate were measured.
  • the resulting chitosan had a piotination rate of 0.02 to 0.1 (mol / mol).
  • a platinum / gold nanocolloid solution was prepared in the same manner as in Example 3.
  • Fig. 5 shows the results of measurement of the residual ratio of superoxide on the obtained pyotinchitosan / platinum / gold nanocolloid solution. Even when using chitosan with pyotiny, the ability to eliminate superoxide two ions was maintained.
  • pectin (UNIPECTINE AYD30, a reagent manufactured by Dutec Foods Co., Ltd.) in distilled water over 1 hour, add 10 ml of pectin solution adjusted to a concentration of 1.98 g / L, Stir for 1 hour. Thereafter, the solvent was removed with an evaporator and then redispersed with 33.2 ml of distilled water to obtain a sample solution.
  • pectin UNIPECTINE AYD30, a reagent manufactured by Dutec Foods Co., Ltd.
  • Example 9 no pectin, comparative example
  • Example 10 Commercially available Evian (500 ml, Sodium 2.5 mg (0.22 mM), Calcium 39 mg (1.95 mM), Magnesium 12 mg (l mM) in hardness 291 degree medium hard water, pH 7.2) was used as hard water. .
  • Evian 500 ml, Sodium 2.5 mg (0.22 mM), Calcium 39 mg (1.95 mM), Magnesium 12 mg (l mM) in hardness 291 degree medium hard water, pH 7.2
  • Example 13 The pH stability was examined using the sample of Example 10 (CP-PT) and platinum nanocolloid (PAA-Pt) using polyacrylic acid. Using a spectrophotometer (Amersham Ultrospec 6300 pro), measure the extinction rate of 400 M hydrogen peroxide by hydrogen peroxide spectral absorption (210 nm), and calculate the activity of platinum nanocolloid from the remaining absorbance did. The result is shown in FIG. From this result, it can be seen that, compared with the conventional nanocolloid, the platinum nanocolloid of Example 10 has significantly less influence on the activity due to pH fluctuation.
  • the noble metal nanocolloid solution contained in the superoxide-on scavenger of the present invention retains high reaction efficiency as a noble metal catalyst, and is excellent in intracellular uptake of noble metal nanoparticles. Therefore, the superoxide-on scavenger of the present invention is useful as a scavenger having extremely high activity.
  • the erasing agent of the present invention has extremely desirable properties when added to beverages or foods.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

A precious metal nanocolloid solution comprising nanoparticles of a precious metal, such as platinum, gold or a mixture thereof, and a polysaccharide derived from natural products, such as pectin and chitosan. The precious metal nanocolloid solution retains high reactivity as a precious metal catalyst, excelling in cellular intake performance, and is free from problems, such as unpleasant odor. Further, there is provided a superoxide anion scavenger comprising the precious metal nanocolloid solution.

Description

明 細 書  Specification
貴金属ナノコロイド溶液  Precious metal nano colloid solution
技術分野  Technical field
[0001] 本発明は白金などの貴金属のナノ粒子を含み、高いスーパーオキサイドァ-オン 消去能を有する貴金属ナノコロイド溶液に関する。  [0001] The present invention relates to a noble metal nanocolloid solution containing nanoparticles of noble metals such as platinum and having high superoxide-on erasing ability.
背景技術  Background art
[0002] 白金ナノ粒子とポリアクリル酸塩とを含有し、スーパーオキサイドァ-オンを半減す る濃度が 200 モル Zリットル以下である白金ナノコロイド溶液が知られている(国際 公開 WO2005/023467)。この発明の好ましい形態では、保護材としてポリアクリル酸 塩 (ナトリウムまたはカリウム塩)を用いており、 R値 (モノマー単位あたりに換算したポ リアクリル酸塩のモル数と白金のモル数との比率)が 80から 180の間となるように白金 ナノコロイド溶液を調製する。この白金ナノコロイド溶液中に含まれる白金ナノ粒子の 90%以上の粒径は 0.1から 10 nmの間に分布している。また、貴金属を含む 2元ナノコ ロイド溶液としては、特開平 9-225317号公報などに、ニッケルと貴金属とを含む触媒 、とくに水素化触媒としての使用などが開示されている。特開平 9-225317号公報に 記載された発明の好まし 、態様では、保護材として環状アミド構造をもつビュル系ポ リマー、とくにポリビニルピロリドン、とりわけポリ N—ビニルー 2—ピロリドンがもっとも 活性の高 、触媒となるので好ま ヽとされており、 R値 (モノマー対全金属のモル比) で 0.1〜 100、好ましくは 1〜20であるとされて!/、る。  [0002] A platinum nanocolloid solution containing platinum nanoparticles and a polyacrylate and having a concentration that halves superoxide-one is 200 mol Z liter or less is known (International Publication WO2005 / 023467) . In a preferred embodiment of the present invention, polyacrylic acid salt (sodium or potassium salt) is used as a protective material, and R value (ratio of moles of polyacrylate converted to monomer units and moles of platinum). Prepare a platinum nanocolloid solution so that is between 80 and 180. The particle size of 90% or more of platinum nanoparticles contained in this platinum nanocolloid solution is distributed between 0.1 and 10 nm. As a binary nanocolloid solution containing a noble metal, JP-A-9-225317 discloses use of a catalyst containing nickel and a noble metal, particularly as a hydrogenation catalyst. In a preferred embodiment of the invention described in JP-A-9-225317, a bull polymer having a cyclic amide structure as a protective material, particularly polyvinyl pyrrolidone, particularly poly N-vinyl-2-pyrrolidone, has the highest activity. It is preferred because it becomes a catalyst, and the R value (molar ratio of monomer to total metal) is 0.1 to 100, preferably 1 to 20! /.
[0003] し力しながら、従来提案されている上記の貴金属ナノコロイド溶液はいずれも R値が 大きぐ貴金属の触媒としての反応効率が低下し、細胞内への貴金属粒子の取り込 みが少ないという欠点を有している。例えば、本発明者らの研究により、これらの貴金 属ナノコロイド溶液は、短時間(1分以内)のスーパーオキサイドァ-オン消去能や細 胞膜に対する接近能力、又はターゲット性においてビタミン Cと比較して劣る場合が あることが判明している。また、上記国際公開 WO2005/023467ゃ特開平 9-225317号 公報などに開示された貴金属ナノコロイド溶液で用いられるポリアクリル酸塩やポリビ -ルピロリドンなどの保護材は特異な不快臭を有するという問題もある。上記の理由 から、貴金属触媒として高い反応効率を保持しており、細胞内取り込み性に優れ、か つ不快臭などの問題を回避した貴金属ナノコロイド溶液の提供が望まれている。 [0003] However, all of the above-mentioned noble metal nanocolloid solutions proposed so far have a low R reaction efficiency as a catalyst for a noble metal having a large R value, and there is little uptake of noble metal particles into cells. Has the disadvantages. For example, according to the study by the present inventors, these noble metal nanocolloid solutions have a short time (within 1 minute) of superoxide-on elimination ability, ability to access cell membranes, or target ability with vitamin C. It has been found that it may be inferior in comparison. Further, the protective material such as polyacrylate and polyvinylpyrrolidone used in the noble metal nanocolloid solution disclosed in the above International Publication WO2005 / 023467 and Japanese Patent Laid-Open No. 9-225317 has a problem that it has a specific unpleasant odor. There is also. Reason for the above Therefore, it is desired to provide a noble metal nanocolloid solution that retains high reaction efficiency as a noble metal catalyst, has excellent intracellular uptake, and avoids problems such as unpleasant odor.
[0004] 金ナノコロイド溶液の調製にあたりキトサンを用いる報告があり (K. Esumi, Colloids a nd Surfaces B: Biointerfaces, 32, pp.117- 123, 2003)、得られた金ナノコロイド溶液が ヒドロキシラジカルを消去することが示されて 、るが、スーパーオキサイドァ-オン消 去剤として高い活性を有することは示唆ないし教示されていない。また、金と白金の 2 元ナノコロイドィ匕に関しては、可視光線による水中からの水素発生 (A.Harriman, J. c hem. Soc, Commun., 24, 1990)が知られており、各種貴金属と白金との組み合わせ と水素発生との関係については戸嶋らの報告がある(Toshima, N., Hirakawa.K., Pol ymer J. 3, pp.1127- 1132, 1999))しかしながら、 2元金属ナノコロイドがスーパーォキ サイドア-オン消去剤として高 、活性を有することはこれらの文献には示唆な 、し教 示されていない。 [0004] There is a report that chitosan is used in the preparation of gold nanocolloid solution (K. Esumi, Colloids and Surfaces B: Biointerfaces, 32, pp.117-123, 2003). However, it is not suggested or taught to have high activity as a superoxide-one scavenger. As for binary nanocolloids of gold and platinum, hydrogen generation from water by visible light (A. Harriman, J. chem. Soc, Commun., 24, 1990) is known. However, Toshima, N., Hirakawa. K., Polymer J. 3, pp. 1127-1132, 1999) reported the relationship between the combination of the two and the hydrogen evolution. These documents do not suggest or teach that they have high activity as superoxide-on scavengers.
[0005] また、アルギン酸塩、澱粉、グリコーゲン、ゼラチン、ぺクチン、キトサン、キチン質、 セルロースおよびその誘導体、アラビアゴム、ローカストビーンゴム、カラャゴム、トラ ガカントゴム、ガティゴム、ァガーァガー、力ラゲ一ニン、イナゴマメゴム、グアーゴム、 及びキサンタンゴム力 なる群力 選択される親水コロイドを含む親水コロイド包帯で あって、ナノ結晶性の白金を配合した包袋が知られている(特表 2004-529930号公報 )。し力しながら、この発明ににおける「親水コロイド」とは、水およびポリオール (膨潤 剤)の存在下で増粘性ゲルを形成することができるポリマー (合成的に調製されたか、 あるいは天然に存在するポリマー)を意味しており、膨潤剤は選択した親水コロイドを 膨潤させてゲル相を形成する作用を有して 、ることから、ナノコロイドの調製にぉ 、て 用いられる保護材のように金属に配位して 、る状態のものではな 、。  [0005] Also, alginate, starch, glycogen, gelatin, pectin, chitosan, chitin, cellulose and its derivatives, gum arabic, locust bean gum, cara gum, gum tragacanth, gati gum, agar agar, power laginin, locust bean gum , Guar gum, and xanthan gum group strength is a hydrocolloid dressing containing a selected hydrocolloid, and a sachet containing nanocrystalline platinum is known (Japanese Patent Publication No. 2004-529930). However, the term “hydrocolloid” in this invention means a polymer (synthetically prepared or naturally occurring) that can form a thickening gel in the presence of water and a polyol (swelling agent). Polymer), and the swelling agent has the action of swelling the selected hydrocolloid to form a gel phase, so that it is a metal like a protective material used in the preparation of nanocolloids. It is not in a state of being coordinated with.
非特許文献 1 : Colloids and Surfaces B: Biointerfaces, 32, pp.117- 123, 2003 非特許文献 2 : J. Chem. Soc, Commun., 24, 1990  Non-patent document 1: Colloids and Surfaces B: Biointerfaces, 32, pp.117-123, 2003 Non-patent document 2: J. Chem. Soc, Commun., 24, 1990
非特許文献 3 : Polymer J. 3, pp.1127- 1132, 1999  Non-Patent Document 3: Polymer J. 3, pp. 1127-1132, 1999
特許文献 1:国際公開 WO2005/023467  Patent Document 1: International Publication WO2005 / 023467
特許文献 2:特開平 9-225317号公報  Patent Document 2: Japanese Patent Laid-Open No. 9-225317
特許文献 3:特表 2004-529930号公報 発明の開示 Patent Document 3: Japanese Translation of Special Publication 2004-529930 Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0006] 本発明の課題は、新規な貴金属ナノコロイド溶液を提供することにある。より具体的 には、貴金属触媒として高い反応効率を保持しており、細胞内取り込み性に優れ、か つ不快臭などの問題のない貴金属ナノコロイド溶液を提供することが本発明の課題 である。  [0006] An object of the present invention is to provide a novel noble metal nanocolloid solution. More specifically, it is an object of the present invention to provide a noble metal nanocolloid solution that retains high reaction efficiency as a noble metal catalyst, has excellent intracellular uptake, and has no problems such as unpleasant odor.
課題を解決するための手段  Means for solving the problem
[0007] 本発明者らは上記の課題を解決すべく鋭意研究を行なった結果、キトサン又はべ クチンなどの天然物由来多糖類を保護材として用いて貴金属ナノコロイド溶液を調製 すると、得られた貴金属ナノコロイド溶液が貴金属触媒として高い反応効率を保持し ており、かつ細胞内取り込み性に優れていることを見出した。そして、この貴金属ナノ コロイド溶液を極めて高い活性を有するスーパーオキサイドァ-オン消去剤として使 用できることを見出した。本発明は上記の知見を基にして完成された。 [0007] As a result of intensive studies to solve the above-mentioned problems, the present inventors obtained a precious metal nanocolloid solution using a natural product-derived polysaccharide such as chitosan or bectin as a protective material. It was found that the noble metal nanocolloid solution retains high reaction efficiency as a noble metal catalyst and is excellent in cellular uptake. The inventors have found that this noble metal nanocolloid solution can be used as a superoxide-on scavenger having extremely high activity. The present invention has been completed based on the above findings.
[0008] すなわち、本発明により、貴金属ナノ粒子及び天然物由来多糖類を含む貴金属ナ ノコロイド溶液を含むスーパーオキサイドァ-オン消去剤が提供される。 That is, according to the present invention, there is provided a superoxide-on scavenger comprising a noble metal nanocolloid solution containing noble metal nanoparticles and a natural product-derived polysaccharide.
この発明の好ましい態様によれば、 R値が 3〜4の範囲である上記のスーパーォキ サイドア-オン消去剤、貴金属として白金及び金からなる 2種の貴金属を含む上記の スーパーオキサイドァ-オン消去剤、天然物由来多糖類がキトサン、ぺクチン、又は それらの混合物である上記のスーパーオキサイドァニオン消去剤が提供される。 別の観点からは、ヒトを含む哺乳類の生体内でスーパーオキサイドァ-オンを消去 する方法であって、貴金属ナノ粒子及び天然物由来多糖類を含む貴金属ナノコロイ ド溶液をヒトを含む哺乳類動物に投与する工程を含む方法が本発明により提供され る。  According to a preferred embodiment of the present invention, the above superoxide-on erasing agent having an R value in the range of 3 to 4, the above superoxide-on erasing agent comprising two kinds of noble metals consisting of platinum and gold as noble metals The above superoxide anion scavenger is provided wherein the natural product-derived polysaccharide is chitosan, pectin, or a mixture thereof. From another viewpoint, there is a method for eliminating superoxide-one in the living body of mammals including humans, in which a noble metal nanocolloid solution containing noble metal nanoparticles and a natural product-derived polysaccharide is administered to mammals including humans. There is provided by the present invention a method comprising the steps of:
さらに、本発明により、貴金属ナノ粒子及び天然物由来多糖類を含む貴金属ナノコ ロイド溶液を含む飲料又は食品が提供される。  Furthermore, the present invention provides a beverage or food containing a noble metal nanocolloid solution containing noble metal nanoparticles and a natural product-derived polysaccharide.
図面の簡単な説明  Brief Description of Drawings
[0009] [図 1]キトサン/白金 ·金ナノコロイド溶液において金の含有率を変化させた場合のス 一パーォキシドア-オン残存率を示した図である。 [0009] [Fig.1] Chitosan / platinum / gold nanocolloid solution with different gold content It is the figure which showed the one peroxyd-on residual rate.
[図 2]ぺクチン/白金 '金ナノコロイド溶液において金の含有率を変化させた場合のス 一パーォキシドア-オン残存率を示した図である。  FIG. 2 is a graph showing the percentage of remaining superoxide-on when the content of gold is changed in a pectin / platinum gold nanocolloid solution.
[図 3]キトサン/白金 ·金ナノコロイド溶液(白金:金 = 1:1)においてキトサン濃度を変化 させた場合のスーパーォキシドア-オン残存率を示した図である。  FIG. 3 is a graph showing the superoxide-on residual ratio when chitosan concentration is changed in a chitosan / platinum / gold nanocolloid solution (platinum: gold = 1: 1).
[図 4]ぺクチン/白金 ·金ナノコロイド溶液(白金:金 = 1:1)においてぺクチン濃度を変 化させた場合のスーパーォキシドア-オン残存率を示した図である。  FIG. 4 is a graph showing the superoxide-on residual rate when the pectin concentration is changed in a pectin / platinum / gold nanocolloid solution (platinum: gold = 1: 1).
[図 5]ピオチンィ匕キトサン/白金 ·金ナノコロイド溶液(白金:金 = 1:1)についてスーパー ォキシドア-オン残存率を測定した結果を示した図である。  FIG. 5 is a graph showing the results of measuring the superoxide-on residual ratio for a pyotinchitosan / platinum / gold nanocolloid solution (platinum: gold = 1: 1).
[図 6]本発明の白金ナノコロイド溶液 (CP-PT)とポリアクリル酸を用いた白金ナノコロ イド (PAA-Pt)の pH安定性を測定した結果を示した図である。  FIG. 6 is a diagram showing the results of measuring the pH stability of platinum nanocolloid (PAA-Pt) using platinum nanocolloid solution (CP-PT) and polyacrylic acid of the present invention.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0010] 本発明のスーパーオキサイドァ-オン消去剤に含まれる貴金属ナノコロイド溶液は 、貴金属ナノ粒子及び天然物由来多糖類を含むことを特徴として 、る。 [0010] The noble metal nanocolloid solution contained in the superoxide-on scavenger of the present invention is characterized by containing noble metal nanoparticles and a natural product-derived polysaccharide.
貴金属の種類は特に限定されず、金、ルテニウム、ロジウム、パラジウム、オスミウム 、イリジム、又は白金のいずれを用いてもよいが、好ましい貴金属は金、ルテニウム、 ロジウム、パラジウム、又は白金である。これらのうち、金又は白金が好ましい。また、 金と白金の 2つを組み合わせて用いることも好ま 、。 2種以上の貴金属を含む貴金 属ナノコロイド溶液を調製する場合には、 2種以上の貴金属微粒子を含む混合物又 は 2種以上の貴金属の合金などを用いることができる。本発明の貴金属ナノコロイド 溶液中には、貴金属以外の 1種又は 2種以上の金属のナノ粒子が存在していてもよ い。  The type of the noble metal is not particularly limited, and any of gold, ruthenium, rhodium, palladium, osmium, iridium, or platinum may be used, but a preferable noble metal is gold, ruthenium, rhodium, palladium, or platinum. Of these, gold or platinum is preferred. It is also preferable to use a combination of gold and platinum. When preparing a noble metal nanocolloid solution containing two or more kinds of noble metals, a mixture containing two or more kinds of noble metal fine particles or an alloy of two or more kinds of noble metals can be used. In the noble metal nanocolloid solution of the present invention, one or more kinds of metal nanoparticles other than the noble metal may be present.
[0011] 天然物由来多糖類としては、例えば、分子内に遊離のカルボキシル基ゃァミノ基な どを有する天然物由来の多糖などが好ましい。例えば、アルギン酸、ヒアルロン酸、キ チン'キトサン、ぺクチン(ぺクチン酸及びぺクチニン酸)、マンヌロン酸、 N-ァセチル ダルコサミン、 D-ガラタトピラノシルゥロン酸、グルクロン酸、ダルコサミン、 N-ァセチル ダルコサミン、メトキシ化した D-ガラタトピラノシルゥロン酸、ラムノガラタツロナン、シク ロデキストリン、アミロぺクチン、メチルセルロースなどを挙げることができる力 これら に限定されることはない。これらのうち、アルギン酸、キチン'キトサン、ヒアルロン酸、 ぺクチン(高メトキシルぺクチン及び低メトキシルぺクチンの 、ずれをも含む)などが 好ましぐ最も好適には低メトキシルぺクチンなどを用いることができる力 これらに限 定されることはな 、。 2種類以上の天然物由来多糖類を組み合わせて用いてもよ!、。 As the natural product-derived polysaccharide, for example, a natural product-derived polysaccharide having a free carboxyl group or amino group in the molecule is preferable. For example, alginic acid, hyaluronic acid, chitin 'chitosan, pectin (pectinic acid and pectinic acid), mannuronic acid, N-acetyl darcosamine, D-galatatopyranosyluronic acid, glucuronic acid, darcosamine, N-acetyl Ability to mention darcosamine, methoxylated D-galatatopyranosyluronic acid, rhamnogalataturonane, cyclodextrin, amylopectin, methylcellulose, etc. It is not limited to. Of these, alginic acid, chitin 'chitosan, hyaluronic acid, pectin (including high methoxyl pectin and low methoxyl pectin, including misalignment), etc. are preferred, and low methoxyl pectin is most preferably used. The power that can be done. You can use two or more natural product-derived polysaccharides in combination!
[0012] 本発明のスーパーオキサイドァ-オン消去剤において、天然物由来多糖類は貴金 属ナノコロイドの保護材として作用する。天然物由来多糖類は、適宜の化学修飾を施 されていてもよい。例えば、必要に応じて適宜のスぺーサ一などを介して他の生理活 性物質と結合できるように化学修飾されたものであってもよい。例えば、キトサンでは ピオチンなどを結合した天然物由来多糖類を用いることができ、貴金属ナノコロイド 溶液を調製した後に種々の生理活性物質などをアビジンに結合させ、生理活性物質 を含む貴金属ナノコロイド溶液を調製することができる。ぺクチンにっ 、ては可溶ィ匕 できる限り配合範囲に制限はなく、二価金属イオンの多!、硬水中でも長期に安定を 保つという特徴があり、特に食品への応用に有利である。また、従来用いられていた ポリアクリル酸ナトリウムに比べて pHの影響を受けることなぐ貴金属ナノコロイドの活 性が安定して 、るなどの特徴もある。 [0012] In the superoxide-one scavenger of the present invention, the natural product-derived polysaccharide acts as a protective material for the noble metal nanocolloid. The natural product-derived polysaccharide may be subjected to appropriate chemical modification. For example, it may be chemically modified so that it can be combined with other physiologically active substances through an appropriate spacer as required. For example, chitosan can use polysaccharides derived from natural products bound with piotin, etc. After preparing a noble metal nanocolloid solution, various bioactive substances are bound to avidin, and noble metal nanocolloid solution containing the bioactive substance is prepared. Can be prepared. Pectin has a characteristic that it is soluble as much as possible, and there are no restrictions on the blending range, it has many divalent metal ions, and it is stable for a long time even in hard water, which is particularly advantageous for food applications. In addition, the activity of precious metal nanocolloids that are not affected by pH is more stable than that of sodium polyacrylate that has been used in the past.
[0013] 貴金属ナノコロイド溶液に含まれる貴金属ナノ粒子の粒径は特に限定されないが、 50 nm以下の平均粒径を有するナノ粒子を用いることができ、好ましくは平均粒径が 2 0 nm以下、さらに好ましくは平均粒径が 10 nm以下、特に好ましくは平均粒径力 〜 6 應程度のナノ粒子を用いることができる。さらに細かなナノ粒子を用いることも可能で ある。貴金属ナノ粒子の 90%以上の粒径が 0.1 nmから 10 nmの範囲に分布することが 好ましい。 [0013] The particle size of the noble metal nanoparticles contained in the noble metal nanocolloid solution is not particularly limited, but nanoparticles having an average particle size of 50 nm or less can be used, preferably the average particle size is 20 nm or less, More preferably, nanoparticles having an average particle size of 10 nm or less, particularly preferably an average particle size of about 6 to 6 can be used. It is also possible to use finer nanoparticles. It is preferable that 90% or more of the noble metal nanoparticles have a particle size distribution in the range of 0.1 nm to 10 nm.
[0014] 遷移金属微粒子、好ましくは貴金属微粒子の製造方法は種々知られており(例え ば、特公昭 57-43125号公報、特公昭 59-120249号公報、及び特開平 9-225317号公 報、特開平 10-176207号公報、特開 2001-79382号公報、特開 2001-122723号公報な ど)、当業者はこれらの方法を参照することによって本発明のスーパーオキサイドァ- オン消去剤に含まれる貴金属ナノコロイド溶液を容易に調製することができる。例え ば、貴金属ナノ粒子の製造方法として、沈殿法又は金属塩還元反応法と呼ばれる化 学的方法、あるいは燃焼法と呼ばれる物理的方法などを利用できる。本発明のスー パーオキサイドァ-オン消去剤に含まれる貴金属ナノコロイド溶液は、いずれの方法 で調製されたナノ粒子を含んで 、てもよ 、が、製造の容易性と品質面から金属塩還 元反応法で調製されたナノ粒子を用いることが好まし 、。 [0014] Various methods for producing transition metal fine particles, preferably noble metal fine particles are known (for example, Japanese Patent Publication No. 57-43125, Japanese Patent Publication No. 59-120249, and Japanese Patent Application Laid-Open No. 9-225317, JP-A-10-176207, JP-A-2001-79382, JP-A-2001-122723, etc.), those skilled in the art refer to these methods and include them in the superoxide-on eraser of the present invention. The precious metal nanocolloid solution can be easily prepared. For example, as a method for producing noble metal nanoparticles, a chemical method called a precipitation method or a metal salt reduction reaction method, or a physical method called a combustion method can be used. Sue of the present invention The noble metal nanocolloid solution contained in the peroxide-on scavenger may contain nanoparticles prepared by any method, but it is a metal salt reduction reaction method from the viewpoint of ease of production and quality. It is preferable to use prepared nanoparticles.
[0015] 金属塩還元反応法では、例えば、水溶性若しくは有機溶媒可溶性の貴金属塩又 は貴金属錯体の水溶液又は有機溶媒溶液を調製し、この溶液に天然物由来多糖類 を加えた後、溶液の pHを 9〜11に調節し、不活性雰囲気下で加熱還流することにより 還元して貴金属ナノ微粒子を含む貴金属ナノコロイド溶液を得ることができる。貴金 属の水溶性又は有機溶媒可溶性の塩の種類は特に限定されないが、例えば、酢酸 塩、塩化物、硫酸塩、硝酸塩、スルホン酸塩、又はリン酸塩などを用いることができ、 これらの錯体を用いてもよい。天然物由来多糖類の使用量は特に限定されないが、 通常は溶液の全重量に対して 0.005〜0.1重量%程度であり、好ましくは 0.01〜0.025 重量%程度である。上記の反応に際して、各種の界面活性剤、例えばァニオン性、 ノ-オン性、又は脂溶性等の界面活性剤を使用することも可能である。還元をアルコ ールを用いて行う際には、エチルアルコール、 n-プロピルアルコール、 n-ブチルアル コール、 n-ァミルアルコール、又はエチレングリコールなどが用いられる。もっとも、貴 金属ナノ粒子の調製方法は上記に説明した方法に限定されることはない。 [0015] In the metal salt reduction reaction method, for example, an aqueous solution or an organic solvent solution of a water-soluble or organic solvent-soluble noble metal salt or noble metal complex is prepared, and a natural product-derived polysaccharide is added to this solution. By adjusting the pH to 9 to 11 and heating to reflux in an inert atmosphere, reduction can be performed to obtain a noble metal nanocolloid solution containing noble metal nanoparticles. The type of water-soluble or organic solvent-soluble salt of the noble metal is not particularly limited, but for example, acetate, chloride, sulfate, nitrate, sulfonate, phosphate, etc. can be used. A complex may be used. The amount of the natural product-derived polysaccharide is not particularly limited, but is usually about 0.005 to 0.1% by weight, preferably about 0.01 to 0.025% by weight, based on the total weight of the solution. In the above reaction, various surfactants such as anionic, non-ionic, or fat-soluble surfactants may be used. When the reduction is performed using alcohol, ethyl alcohol, n -propyl alcohol, n-butyl alcohol, n-amyl alcohol, ethylene glycol, or the like is used. However, the method for preparing the noble metal nanoparticles is not limited to the method described above.
[0016] 典型的には、貴金属塩の水溶液にアルコール、ヒドラジン、テトラヒドロホウ酸ナトリ ゥム、又はクェン酸等の還元剤を添加して溶媒沸点近傍に加温し、溶媒還流、紫外 線照射、及び超音波照射などを組み合わせて貴金属の還元反応を行なった後に溶 媒を除いて乾固し、得られた貴金属ナノ粒子を所望の溶媒に懸濁することにより貴金 属ナノコロイド溶液を調製する kとができる。本発明のスーパーオキサイドァ-オン消 去剤に含まれる貴金属ナノコロイド溶液は、分散媒が実質的に水のみ力 なることが 好ま 、が、エタノールやグリセリンなどの水と混じりあう有機溶媒を少量含んで!/、て ちょい。  [0016] Typically, a reducing agent such as alcohol, hydrazine, sodium tetrahydroborate, or citrate is added to an aqueous solution of a noble metal salt and heated near the boiling point of the solvent, solvent reflux, ultraviolet irradiation, After the noble metal reduction reaction is combined with ultrasonic irradiation, the solvent is removed to dryness, and the resulting noble metal nanoparticles are suspended in a desired solvent to prepare a noble metal nanocolloid solution. k. In the noble metal nanocolloid solution contained in the superoxide-one quencher of the present invention, the dispersion medium is preferably substantially water-powered, but contains a small amount of an organic solvent mixed with water such as ethanol or glycerin. And!
[0017] 本発明のスーパーオキサイドァ-オン消去剤としては、上記の方法により調製され た貴金属ナノコロイド溶液をそのまま用いてもょ 、。本明細書にぉ 、て用いられる「貴 金属ナノコロイド溶液」の用語には、貴金属ナノ粒子が会合してクラスターを形成した 水性分散液も包含される。また、「ナノ」の用語は、貴金属微粒子の平均粒径が一般 的にナノメーターのオーダーで測定可能であることを意味しているが、いかなる意味 においても限定的に解釈してはならない。例えば、平均粒径が 0.01 nm程度の微粒 子も本明細書で用いられるナノ粒子の範囲に包含される。 [0017] As the superoxide-on scavenger of the present invention, the noble metal nanocolloid solution prepared by the above method may be used as it is. The term “noble metal nanocolloid solution” used herein includes an aqueous dispersion in which noble metal nanoparticles are associated to form a cluster. The term “nano” generally refers to the average particle size of noble metal fine particles. This means that it can be measured on the order of nanometers, but it should not be interpreted in a limited way in any way. For example, fine particles having an average particle size of about 0.01 nm are also included in the range of nanoparticles used in the present specification.
[0018] いかなる特定の理論に拘泥するわけではないが、キトサン又はぺクチンなどの天然 物由来多糖類を保護材として用いることにより、本発明のスーパーオキサイドァ-ォ ン消去剤に含まれる貴金属ナノコロイド溶液は R値が 80未満、好ましくは 40未満、より 好ましくは 5未満、特に好ましくは 3から 4の範囲内であり、従来の貴金属ナノコロイド 溶液に比べ遙かに小さい (R値については技術情報協会「金属ナノ粒子の合成'調 製、コントロール技術と応用展開(2004年 12月 22日発刊)」を参照のこと)。本発明に おいては R値はモノマー単位あたりに換算した天然物由来多糖類のモル数と白金の モル数との比率を意味する)。この性質により、本発明のスーパーオキサイドァ-オン 消去剤では貴金属ナノ粒子の反応性が極めて高ぐまた細胞接近性が非常に高いと いう特徴がある。また、 1分以内の初期反応が向上し、効率的に貴金属ナノコロイド溶 液を調製することができるという特徴もある  [0018] Without being bound to any particular theory, the use of a natural product-derived polysaccharide such as chitosan or pectin as a protective material allows the noble metal nano-particles contained in the superoxide-on scavenger of the present invention. The colloidal solution has an R value of less than 80, preferably less than 40, more preferably less than 5, particularly preferably in the range of 3 to 4, which is much smaller than conventional noble metal nanocolloid solutions. (See Information Association “Synthesis of Metal Nanoparticles”, Control Technology and Application Development (published on December 22, 2004)). In the present invention, the R value means the ratio between the number of moles of the natural product-derived polysaccharide and the number of moles of platinum converted per monomer unit). Due to this property, the superoxide-one scavenger of the present invention is characterized in that the reactivity of the noble metal nanoparticles is extremely high and the cell accessibility is very high. In addition, the initial reaction within 1 minute is improved, and the precious metal nanocolloid solution can be efficiently prepared.
[0019] 本発明のスーパーオキサイドァ-オン消去剤は医薬としてヒトを含む哺乳類動物に 投与し、生体内においてスーパーオキサイドァ-オンの消去作用を発揮できる。また 、本発明のスーパーオキサイドァニオン消去剤は、スーパーオキサイドァニオンの消 去作用を有する飲料、特に飲料水として使用することができる。また、本発明のスー パーオキサイドァ-オン消去剤を食品に添加したり、加工食品の製造に用いたりして 、本発明のスーパーオキサイドァ-オン消去剤を含む食品を調製して健康食品とし て用いることもできる。さら〖こ、本発明のスーパーオキサイドァ-オン消去剤は化粧料 に配合することにより美肌又は美白効果などを発揮させることができ、あるいは医療 用具又は歯科材料の調製や、細胞培養用の培地の調製などに用いることも可能であ る。  [0019] The superoxide-one-eliminating agent of the present invention can be administered as a pharmaceutical to mammals including humans, and can exert the superoxide-one-eliminating action in vivo. Further, the superoxide anion scavenger of the present invention can be used as a beverage having a superoxide anion erasing action, particularly as drinking water. In addition, the superoxide-on-eliminating agent of the present invention is added to foods or used in the manufacture of processed foods to prepare foods containing the superoxide-on-eliminating agent of the present invention as health foods. Can also be used. Furthermore, the superoxide-on-eliminating agent of the present invention can exert a skin beautifying effect or a whitening effect by adding it to cosmetics, or can be used for the preparation of medical devices or dental materials, or for the medium for cell culture. It can also be used for preparation.
実施例  Example
[0020] 以下、実施例により本発明をさらに具体的に説明するが、本発明の範囲は下記の 実施例に限定されることはない。  Hereinafter, the present invention will be described more specifically with reference to examples. However, the scope of the present invention is not limited to the following examples.
例 1 100 mLのナスフラスコにキトサン 2 mg (焼津水産化学工業製、 COS- Y、 12.4 ^ mol) と精製水 19.7 mL (milli-Q)をカ卩えて室温で 10分間攪拌した後、テトラクロ口金酸 4水 和物水溶液 0.2 mL (和光純薬工業製、 1.66 X 10— 2M, 3.32 mol)を加えた。室温で 6 0分攪拌した後、冷却した NaBH水溶液 0.1 mL (和光純薬工業製、 0.4 M)をカ卩えてさ Example 1 In a 100 mL eggplant flask, 2 mg of chitosan (Yaizu Suisan Chemical Co., Ltd., COS-Y, 12.4 ^ mol) and 19.7 mL of purified water (milli-Q) were added and stirred for 10 minutes at room temperature. hydrate solution 0.2 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) was added. After stirring at room temperature for 60 minutes, hold 0.1 mL of cooled NaBH aqueous solution (Wako Pure Chemical Industries, 0.4 M).
4  Four
らに 30分攪拌を続け、その後にー晚静置して紅色透明溶液 (キトサン/金ナノコロイド 溶液、 166 /z M)を得た。このキトサン/金ナノコロイド溶液の R値を技術情報協会「金 属ナノ粒子の合成'調製、コントロール技術と応用展開」に記載された方法に準じて 測定したところ 3.7であった。  The mixture was further stirred for 30 minutes, and then left to stand to obtain a red transparent solution (chitosan / gold nanocolloid solution, 166 / z M). The R value of this chitosan / gold nanocolloid solution was measured according to the method described in the Technical Information Association “Synthesis of Metal Nanoparticles” Preparation, Control Technology and Application Development ”to be 3.7.
[0021] 例 2 [0021] Example 2
テトラクロ口金酸 4水和物水溶液 0.2 mLをテトラクロ口白金酸 6水和物水溶液 0.2 m L (和光純薬工業製、 1.66 X 10— 2M, 3.32 /z mol)に変更した以外は例 1と同様にしてキ トサン/白金ナノコロイド溶液を得た。 Tetrachloroethene mouthpiece acid tetrahydrate aqueous solution 0.2 mL of tetrachloroethene port chloroplatinic acid hexahydrate solution 0.2 m L (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 / z mol) was changed to the Example 1 Similarly, a chitosan / platinum nanocolloid solution was obtained.
例 3  Example 3
例 1において、テトラクロ口金酸 4水和物水溶液 0.2 mLに替えて、テトラクロ口金酸 4 水和物水溶液 0.1 mL (和光純薬工業製、 1.66 X 10— 2M, 3.32 mol)及びテトラクロ口 白金酸 6水和物水溶液 0.1 mL (和光純薬工業製、 1.66 X 10— 2M, 3.32 mol)の混合 物を用いた以外は、例 1と同様にしてキトサン/白金 ·金ナノコロイド溶液を得た。同様 にして、テトラクロ口金酸 4水和物水溶液及びテトラクロ口白金酸 6水和物水溶液の比 率が異なる混合物を用いて、金の含有率が異なるキトサン/白金 ·金ナノコロイド溶液 を調製した。 In Example 1, in place of the tetrachloroethene mouthpiece acid tetrahydrate aqueous solution 0.2 mL, tetrachloroethene mouthpiece acid tetrahydrate aqueous 0.1 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) and tetrachloroethene port chloroplatinic acid hexahydrate solution 0.1 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) except for using a mixture of, in the same manner as in example 1 to obtain a chitosan / platinum-gold nano colloid solution . Similarly, chitosan / platinum / gold nanocolloid solutions having different gold contents were prepared by using mixtures having different ratios of tetrachlorodiaurate tetrahydrate aqueous solution and tetrachlorodioctaplatinate hexahydrate aqueous solution.
[0022] 例 4 [0022] Example 4
100 mLのナスフラスコにぺクチン 2 mg (ュ-テックフーズ、 12.4 mol)と精製水 19. 7 mL (milli-Q)を加えて室温で 10分間攪拌した後、テトラクロ口金酸 4水和物水溶液 0 .2 mL (和光純薬工業製、 1.66 X 10— 2M, 3.32 mol)をカ卩えた。室温で 60分攪拌した 後、冷却した NaBH水溶液 0.1 mL (和光純薬工業製、 0.4 M)をカ卩えてさらに 30分攪 To a 100 mL eggplant flask, add 2 mg (petech foods, 12.4 mol) of pectin and 19.7 mL (milli-Q) of purified water and stir at room temperature for 10 minutes. 0 .2 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) to give a mosquito卩. After stirring for 60 minutes at room temperature, add 0.1 mL of cooled NaBH aqueous solution (Wako Pure Chemical Industries, 0.4 M) and stir for another 30 minutes.
4  Four
拌を続け、その後にー晚静置して紅色透明溶液 (ぺクチン/金ナノコロイド溶液、 166 μ Μ)を得た。このぺクチン/金ナノコロイド溶液の R値を例 1に記載された方法に準じ て測定したところ 3.7であった。 [0023] 例 5 Stirring was continued, and then the mixture was allowed to stand to obtain a red transparent solution (pectin / gold nanocolloid solution, 166 μΜ). When the R value of this pectin / gold nanocolloid solution was measured according to the method described in Example 1, it was 3.7. [0023] Example 5
テトラクロ口金酸 4水和物水溶液 0.2 mLをテトラクロ口白金酸 6水和物水溶液 0.2 m L (和光純薬工業製、 1.66 X 10— 2M, 3.32 mol)に変更した以外は例 4と同様にしてぺ クチン/白金ナノコロイド溶液を得た。 Tetrachloroethene mouthpiece acid 4 hydrate aqueous solution 0.2 mL tetrachloroethene port chloroplatinic acid hexahydrate solution 0.2 m L in the same manner as (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) Example 4 was changed to A pectin / platinum nanocolloid solution was obtained.
例 6  Example 6
例 4において、テトラクロ口金酸 4水和物水溶液 0.2 mLに替えて、テトラクロ口金酸 4 水和物水溶液 0.1 mL (和光純薬工業製、 1.66 X 10— 2M, 3.32 mol)及びテトラクロ口 白金酸 6水和物水溶液 0.1 mL (和光純薬工業製、 1.66 X 10— 2M, 3.32 mol)の混合 物を用いた以外は、例 1と同様にしてキトサン/白金 ·金ナノコロイド溶液を得た。同様 にして、テトラクロ口金酸 4水和物水溶液及びテトラクロ口白金酸 6水和物水溶液の比 率が異なる混合物を用いて、金の含有率が異なるぺクチン/白金 ·金ナノコロイド溶液 を調製した。 In Example 4, instead of tetrachloroethene mouthpiece acid tetrahydrate aqueous solution 0.2 mL, tetrachloroethene mouthpiece acid tetrahydrate aqueous 0.1 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) and tetrachloroethene port chloroplatinic acid hexahydrate solution 0.1 mL (manufactured by Wako Pure Chemical Industries, Ltd., 1.66 X 10- 2 M, 3.32 mol) except for using a mixture of, in the same manner as in example 1 to obtain a chitosan / platinum-gold nano colloid solution . In the same manner, pectin / platinum / gold nanocolloid solutions with different gold contents were prepared using mixtures having different ratios of tetrachlorodiaurate tetrahydrate aqueous solution and tetracroloplatinic acid hexahydrate aqueous solution. .
[0024] 例 7 [0024] Example 7
例 1〜6で調製した貴金属ナノコロイド溶液のスーパーォキシドア-オン消去作用を 検討した。スーパーォキシドア-オン消去作用の評価にはヒポキサンチン (HXN)/キ サンチンォキシダーゼ (XOD)系を用いた。  The superoxide-on elimination action of the noble metal nanocolloid solutions prepared in Examples 1 to 6 was investigated. The hypoxanthine (HXN) / xanthine oxidase (XOD) system was used to evaluate the superoxide-on scavenging action.
(1) 200 mMリン酸バッファー(pH7.5)中に 5.5 mMヒポキサンチンを含む溶液 50 L (1) 50 L solution containing 5.5 mM hypoxanthine in 200 mM phosphate buffer (pH 7.5)
(2) DMPO (5,5-ジメチル- 1-ピロリン- Ν-ォキシド) 15 L (2) DMPO (5,5-Dimethyl-1-pyrroline-Ν-oxide) 15 L
(3)精製水中に 100 Lの試料を含む溶液 (コントロールの場合は精製水のみ) (3) Solution containing 100 L sample in purified water (only purified water for control)
(4) 200 mMリン酸バッファー(pH7.5)中に 0.2 U/mL XODを含む溶液 50 μ L (失活を 防ぐために氷上で保管したもの) (4) 50 μL of a solution containing 0.2 U / mL XOD in 200 mM phosphate buffer (pH 7.5) (stored on ice to prevent inactivation)
以上の (1)〜(4)を混合して 45秒後に測定を行なった。測定条件は以下のとおりである 測定機器: JES— FA100  The measurement was performed 45 seconds after mixing the above (1) to (4). Measurement conditions are as follows Measuring instrument: JES—FA100
周波数: 9420 MHz (値は一定せず微動する)  Frequency: 9420 MHz (value is not constant and moves slightly)
FIELD CENTER: 335.6 mT, Width = +/— 5.000 mT  FIELD CENTER: 335.6 mT, Width = +/— 5.000 mT
POWER: 4.000000 mW, SWEEP TIME = 1.0 min  POWER: 4.000000 mW, SWEEP TIME = 1.0 min
分子量マーカー: 700 [0025] 白金と金を含むナノコロイド溶液にお!、て金の含有率を変化させた場合のスーパ 一ォキシドア-オン残存率を図 1 (キトサン/白金 ·金ナノコロイド溶液)及び図 2 (ぺク チン/白金 '金ナノコロイド溶液)に示す。いずれのナノコロイド溶液についても、金の 含有率が 25〜50%程度の比率にぉ 、て高 、スーパーォキシドア-オン消去能が認 められた。 Molecular weight marker: 700 [0025] In a nanocolloid solution containing platinum and gold, the superoxide-on residual rate when the content of gold is varied is shown in Fig. 1 (chitosan / platinum / gold nanocolloid solution) and Fig. 2 ( Pectin / platinum 'gold nanocolloid solution). In any of the nanocolloid solutions, high superoxide-on erasing ability was confirmed even when the gold content was about 25 to 50%.
図 3及び図 4には、それぞれキトサン及びべクチンの量を変化させた場合の結果を 示す。キトサンについては 0.01重量%、ぺクチンについては 0.01〜0.025重量%程度 で最大の活性が得られた。  Figures 3 and 4 show the results when the amounts of chitosan and bectin were changed, respectively. The maximum activity was obtained at about 0.01% by weight for chitosan and about 0.01-0.025% by weight for pectin.
[0026] 例 8 [0026] Example 8
ピオチンィ匕試薬 (ピオチニレーンヨン'キット (Sulfo- OSu)、同仁ィ匕学研究所製)を用 いてキットのマニュアルに従ってキトサンのピオチンィ匕及びピオチンィ匕率の測定を行 なった。得られたキトサンのピオチン化率は 0.02から 0.1(mol/mol)であった。このピオ チンィ匕キトサンを用いて例 3と同様にして白金 '金ナノコロイド溶液を調製した。得ら れたピオチンィ匕キトサン/白金 ·金ナノコロイド溶液についてスーパーォキシドア-ォ ン残存率を測定した結果を図 5に示す。ピオチンィ匕したキトサンを用いた場合にもス 一パーォキシドア二オン消去能は維持されていた。  Using the Pyotinyi reagent (Piothinilane Yon kit (Sulfo-OSu), manufactured by Dojin University), chitosan's pyotinyi and piotiny rate were measured. The resulting chitosan had a piotination rate of 0.02 to 0.1 (mol / mol). Using this piotinchichitosan, a platinum / gold nanocolloid solution was prepared in the same manner as in Example 3. Fig. 5 shows the results of measurement of the residual ratio of superoxide on the obtained pyotinchitosan / platinum / gold nanocolloid solution. Even when using chitosan with pyotiny, the ability to eliminate superoxide two ions was maintained.
[0027] 例 9 (比較例) [0027] Example 9 (Comparative example)
ァリーン冷却管と三方コックを接続した 100 ml二口ナス底フラスコに、蒸留水 22.6 m 1を入れ、塩化白金酸結晶 (H PtCl ·6Η 0 :和光純薬工業株式会社製試薬)を蒸留  22.6 ml of distilled water was placed in a 100 ml two-necked eggplant bottom flask connected to a water cooling tube and a three-way cock, and chloroplatinic acid crystals (H PtCl · 6Η 0: Reagent manufactured by Wako Pure Chemical Industries, Ltd.) were distilled.
2 6 2  2 6 2
水に溶解し、濃度を 16.6 mMに調製した塩ィ匕白金酸水溶液を 2 ml加え、スターラー チップで撹拌し、還流が起こるまで加熱した。還流が起こった後、クェン酸 3ナトリウム 結晶 (和光純薬工業製試薬)を蒸留水に溶解し、濃度を 38.8 mMに調製したクェン酸 水溶液を 8.6 ml加え、 30分間還流した。反応液の UV-Visスペクトルを測定して、白金 イオンピークが消失し、金属固体特有の散乱による吸収の飽和を確認し、還元反応 が完了したことを確認し、冷却してサンプル溶液を得た。  2 ml of a salt / platinic acid aqueous solution dissolved in water and adjusted to a concentration of 16.6 mM was added, stirred with a stirrer chip, and heated until reflux occurred. After refluxing, trisodium citrate crystals (Wako Pure Chemical Industries reagent) were dissolved in distilled water, and 8.6 ml of an aqueous citrate solution adjusted to a concentration of 38.8 mM was added and refluxed for 30 minutes. Measuring the UV-Vis spectrum of the reaction solution, the platinum ion peak disappeared, the absorption saturation due to the scattering characteristic of the metal solid was confirmed, the reduction reaction was confirmed, and the sample solution was obtained by cooling. .
[0028] 例 10 : [0028] Example 10:
ァリーン冷却管と三方コックを接続した 100 ml二口ナス底フラスコに、蒸留水 22.6 m 1を入れ、塩化白金酸結晶 (H PtCl ·6Η 0 :和光純薬工業株式会社製試薬)を蒸留 水に溶解し、濃度を 16.6 mMに調製した塩ィ匕白金酸水溶液を 2 ml加え、スターラー チップで撹拌し、還流が起こるまで加熱した。還流が起こった後、クェン酸 3ナトリウム 結晶 (和光純薬工業製試薬)を蒸留水に溶解し、濃度を 38.8 mMに調製したクェン酸 水溶液を 8.6 ml加え、 30分間還流した。反応液の UV-Visスペクトルを測定して、白金 イオンピークが消失し、金属固体特有の散乱による吸収の飽和を確認し、還元反応 が完了したことを確認した。室温まで冷却した後、ぺクチン(UNIPECTINE AYD30、 ュ-テックフーズ株式会社製試薬)を蒸留水に 1時間以上かけて溶解し、濃度を 1.98 g/Lに調整したぺクチン溶液を 10 ml加え、 1時間撹拌した。その後、溶媒をエバポレ 一ターで除いた後、蒸留水 33.2 mlで再分散してサンプル溶液を得た。 22.6 ml of distilled water was placed in a 100 ml two-necked eggplant bottom flask connected to a water cooling tube and a three-way cock, and chloroplatinic acid crystals (H PtCl · 6Η 0: Reagent manufactured by Wako Pure Chemical Industries, Ltd.) were distilled. 2 ml of a salt / platinic acid aqueous solution dissolved in water and adjusted to a concentration of 16.6 mM was added, stirred with a stirrer chip, and heated until reflux occurred. After refluxing, trisodium citrate crystals (Wako Pure Chemical Industries reagent) were dissolved in distilled water, and 8.6 ml of an aqueous citrate solution adjusted to a concentration of 38.8 mM was added and refluxed for 30 minutes. By measuring the UV-Vis spectrum of the reaction solution, the platinum ion peak disappeared, and the saturation of absorption due to the scattering characteristic of metal solids was confirmed, confirming that the reduction reaction was complete. After cooling to room temperature, dissolve pectin (UNIPECTINE AYD30, a reagent manufactured by Dutec Foods Co., Ltd.) in distilled water over 1 hour, add 10 ml of pectin solution adjusted to a concentration of 1.98 g / L, Stir for 1 hour. Thereafter, the solvent was removed with an evaporator and then redispersed with 33.2 ml of distilled water to obtain a sample solution.
[0029] 例 11 [0029] Example 11
ァリーン冷却管と三方コックを接続した 100 ml二口ナス底フラスコに、蒸留水 43.8 m 1入れ、塩化白金酸結晶 (H PtCl ·6Η Ο :和光純薬工業株式会社製試薬)を蒸留水  Add 43.8 ml of distilled water to a 100 ml two-necked eggplant bottom flask connected with a water cooling tube and a three-way cock, and add chloroplatinic acid crystals (H PtCl 6Η Η: Reagents manufactured by Wako Pure Chemical Industries, Ltd.)
2 6 2  2 6 2
に溶解し、濃度を 16.6 mMに調製した塩ィ匕白金酸水溶液を 4 ml加え、スターラーチッ プで撹拌し、還流が起こるまで加熱した。還流が起こった後、クェン酸 3ナトリウム結 晶 (和光純薬工業製試薬)を蒸留水に溶解し、濃度を 77.2 mMに調製したクェン酸水 溶液を 8.6 ml加え、 30分間還流した。反応液の UV-Visスペクトルを測定して、白金ィ オンピークが消失し、金属固体特有の散乱による吸収の飽和を確認し、還元反応が 完了したことを確認した。室温まで冷却した後、ぺクチン(UNIPECTINE AYD30、ュ 二テックフーズ株式会社製試薬)を蒸留水に 1時間以上かけて溶解し、濃度を 3.96g/ Lに調整したぺクチン溶液を 10 mlカ卩え、 1時間撹拌してサンプル溶液を得た。  4 ml of a salt / platinic acid aqueous solution prepared at a concentration of 16.6 mM was added, stirred with a stirrer chip, and heated until reflux occurred. After refluxing, trisodium citrate crystals (Wako Pure Chemical Industries reagent) were dissolved in distilled water, and 8.6 ml of a citrate aqueous solution adjusted to a concentration of 77.2 mM was added and refluxed for 30 minutes. By measuring the UV-Vis spectrum of the reaction solution, the platinum ion peak disappeared, and the saturation of absorption due to the scattering characteristic of metal solids was confirmed, confirming the completion of the reduction reaction. After cooling to room temperature, dissolve pectin (UNIPECTINE AYD30, reagent manufactured by Nytec Foods Co., Ltd.) in distilled water over 1 hour, and adjust the concentration to 3.96 g / L. A sample solution was obtained by stirring for 1 hour.
[0030] 例 12 [0030] Example 12
例 9 (ぺクチンなし、比較例)及び例 10のサンプル溶液について硬水中での安定性 の違いを検討した。硬水として市販のェビアン(500 ml中、ナトリウム 2.5 mg(0.22 mM) 、カルシウム 39 mg(1.95 mM)、及びマグネシウム 12 mg(l mM)を含む硬度 291度の中 硬水、 pH7.2)を用いた。例 9のサンプルを硬水で 10倍希釈して 1日後に観察したとこ ろ沈殿が生じていた。一方、例 10の試料を 5倍希釈して 1日後に観察したところ均一 分散していた。  The difference in stability in hard water was examined for the sample solutions of Example 9 (no pectin, comparative example) and Example 10. Commercially available Evian (500 ml, Sodium 2.5 mg (0.22 mM), Calcium 39 mg (1.95 mM), Magnesium 12 mg (l mM) in hardness 291 degree medium hard water, pH 7.2) was used as hard water. . When the sample of Example 9 was diluted 10 times with hard water and observed one day later, precipitation occurred. On the other hand, when the sample of Example 10 was diluted 5 times and observed one day later, it was uniformly dispersed.
[0031] 例 13 例 10のサンプル (CP-PT)及びポリアクリル酸を用いた白金ナノコロイド (PAA-Pt)を 用いて pH安定性を検討した。分光光度計 (アマシャム製 Ultrospec 6300 pro)を用い 、過酸化水素の分光吸収 (210 nm)で 400 Mの過酸ィ匕水素の消去率を測定し、残存 する吸光度から白金ナノコロイドの活性を計算した。結果を図 6に示す。この結果から 、従来のナノコロイドに比べて例 10の白金ナノコロイドでは pH変動による活性への影 響が顕著に少な 、ことが分かる。 [0031] Example 13 The pH stability was examined using the sample of Example 10 (CP-PT) and platinum nanocolloid (PAA-Pt) using polyacrylic acid. Using a spectrophotometer (Amersham Ultrospec 6300 pro), measure the extinction rate of 400 M hydrogen peroxide by hydrogen peroxide spectral absorption (210 nm), and calculate the activity of platinum nanocolloid from the remaining absorbance did. The result is shown in FIG. From this result, it can be seen that, compared with the conventional nanocolloid, the platinum nanocolloid of Example 10 has significantly less influence on the activity due to pH fluctuation.
産業上の利用可能性 Industrial applicability
本発明のスーパーオキサイドァ-オン消去剤に含まれる貴金属ナノコロイド溶液は 貴金属触媒として高い反応効率を保持しており、かつ貴金属ナノ粒子の細胞内取り 込み性に優れている。従って、本発明のスーパーオキサイドァ-オン消去剤は、極め て高い活性を有する消去剤として有用である。また、本発明の消去剤は不快臭がな ぐ医薬の有効成分のほか、飲料又は食品に添加するに際して極めて望ましい性質 を有している。  The noble metal nanocolloid solution contained in the superoxide-on scavenger of the present invention retains high reaction efficiency as a noble metal catalyst, and is excellent in intracellular uptake of noble metal nanoparticles. Therefore, the superoxide-on scavenger of the present invention is useful as a scavenger having extremely high activity. In addition to the active pharmaceutical ingredients that have no unpleasant odor, the erasing agent of the present invention has extremely desirable properties when added to beverages or foods.

Claims

請求の範囲 The scope of the claims
[1] 貴金属ナノ粒子及び天然物由来多糖類を含む貴金属ナノコロイド溶液を含むスーパ 一オキサイドァニオン消去剤。  [1] A superoxide vanishing scavenger comprising a noble metal nanocolloid solution containing noble metal nanoparticles and a natural product-derived polysaccharide.
[2] 天然物由来多糖類がキトサン、ぺクチン、又はそれらの混合物である請求項 1に記載 のスーパーオキサイドァニオン消去剤。  [2] The superoxide anion scavenger according to claim 1, wherein the natural product-derived polysaccharide is chitosan, pectin, or a mixture thereof.
[3] 上記貴金属として白金及び金力 なる 2種の貴金属を含む請求項 1又は 2に記載の スーパーオキサイドァ-オン消去剤。 [3] The superoxide-on eraser according to claim 1 or 2, wherein the noble metal contains two kinds of noble metals consisting of platinum and gold.
[4] 白金及び金の割合が約 1: 1であり、キトサンの含有率が貴金属ナノコロイド溶液の全 重量に対して約 0.01重量%である請求項 3に記載のスーパーオキサイドァ-オン消 去剤。 [4] The superoxide-on elimination according to claim 3, wherein the ratio of platinum and gold is about 1: 1, and the content of chitosan is about 0.01% by weight with respect to the total weight of the noble metal nanocolloid solution. Agent.
[5] 白金及び金の割合が約 1: 1であり、ぺクチンの含有率が貴金属ナノコロイド溶液の全 重量に対して約 0.01〜0.025重量%である請求項 3に記載のスーパーオキサイドァ- オン消去剤。  5. The superoxide solution according to claim 3, wherein the ratio of platinum and gold is about 1: 1, and the content of pectin is about 0.01 to 0.025% by weight based on the total weight of the noble metal nanocolloid solution. On eraser.
[6] 貴金属ナノ粒子の 90%以上の粒径が 0.1 nmから 10 nmの範囲に分布する請求項 1な V、し 5の!、ずれか 1項に記載のスーパーオキサイドァ-オン消去剤。  [6] The superoxide-on scavenger according to claim 1, wherein 90% or more of the noble metal nanoparticles have a particle size distributed in the range of 0.1 nm to 10 nm.
PCT/JP2006/305650 2005-03-23 2006-03-22 Precious metal nanocolloid solution WO2006101106A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007509289A JPWO2006101106A1 (en) 2005-03-23 2006-03-22 Precious metal nano colloid solution

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005084362 2005-03-23
JP2005-084362 2005-03-23

Publications (1)

Publication Number Publication Date
WO2006101106A1 true WO2006101106A1 (en) 2006-09-28

Family

ID=37023767

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/305650 WO2006101106A1 (en) 2005-03-23 2006-03-22 Precious metal nanocolloid solution

Country Status (3)

Country Link
JP (1) JPWO2006101106A1 (en)
TW (1) TW200704404A (en)
WO (1) WO2006101106A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007326796A (en) * 2006-06-06 2007-12-20 Geol Kagaku Kk Bleaching agent containing gold colloid and thyrosinase inhibitor
WO2008058693A1 (en) * 2006-11-17 2008-05-22 Ada Cosmetic Gmbh Body care or beauty care product
JP2008255067A (en) * 2007-04-06 2008-10-23 Noevir Co Ltd Antioxidant
JP2008266324A (en) * 2007-03-29 2008-11-06 Kose Corp Liposome composition and external preparation for skin containing liposome composition
JP2009084243A (en) * 2007-10-02 2009-04-23 Pias Arise Kk Horny layer hyaluronic acid production accelerator and external dermatological preparation, cosmetic, and quasi-drug containing horny layer hyaluronic acid production accelerator
JP2009102228A (en) * 2007-10-19 2009-05-14 La Shinshia Kk Gel sheet and water-containing gel composition used for the gel sheet
JP2014518847A (en) * 2011-03-30 2014-08-07 ジーアール インテレクチュアル リザーブ リミティド ライアビリティ カンパニー Novel gold-platinum-based bimetallic nanocrystal suspension, its electrochemical production method, and use thereof
CN111419728A (en) * 2019-01-09 2020-07-17 戴红妹 High-efficiency nano spot-lightening, brightening and moisturizing activating agent and preparation method thereof
CN111821314A (en) * 2020-03-25 2020-10-27 巫远程 Eye drops for treating myopia and cataract and its preparing process
JP7486928B2 (en) 2019-08-09 2024-05-20 株式会社日本触媒 Aqueous dispersion for cosmetics, dispersion protecting agent, and method for producing cosmetics

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103479552B (en) * 2011-08-25 2015-10-21 唯美度科技(北京)有限公司 Crease-resistant easypro eye cream alive and preparation method
CN108024958A (en) * 2015-09-24 2018-05-11 金善实 Biological nano gold Polysaccharide solution and its manufacture method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1160493A (en) * 1997-08-18 1999-03-02 Eiichi Tsukiji Medicine for treating/preventing disease caused by active oxygen or raw material thereof
JP2001010954A (en) * 1999-06-29 2001-01-16 Otsuka Sangyo Kk Protective for oxidative stress
JP2003012523A (en) * 2001-07-05 2003-01-15 Otsuka Yakuhin Kogyo Kk Qol ameliorant for patient suffering from parkinson's disease
JP2004285166A (en) * 2003-03-20 2004-10-14 Masato Tagawa Antioxidant, stabilized gold colloidal solution and method for preparing the same
WO2005023467A1 (en) * 2003-09-03 2005-03-17 Shetech Co., Ltd. Platinum nanocolloid solution, process for producing the same and drink containing platinum nanocolloid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1160493A (en) * 1997-08-18 1999-03-02 Eiichi Tsukiji Medicine for treating/preventing disease caused by active oxygen or raw material thereof
JP2001010954A (en) * 1999-06-29 2001-01-16 Otsuka Sangyo Kk Protective for oxidative stress
JP2003012523A (en) * 2001-07-05 2003-01-15 Otsuka Yakuhin Kogyo Kk Qol ameliorant for patient suffering from parkinson's disease
JP2004285166A (en) * 2003-03-20 2004-10-14 Masato Tagawa Antioxidant, stabilized gold colloidal solution and method for preparing the same
WO2005023467A1 (en) * 2003-09-03 2005-03-17 Shetech Co., Ltd. Platinum nanocolloid solution, process for producing the same and drink containing platinum nanocolloid

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007326796A (en) * 2006-06-06 2007-12-20 Geol Kagaku Kk Bleaching agent containing gold colloid and thyrosinase inhibitor
WO2008058693A1 (en) * 2006-11-17 2008-05-22 Ada Cosmetic Gmbh Body care or beauty care product
JP2008266324A (en) * 2007-03-29 2008-11-06 Kose Corp Liposome composition and external preparation for skin containing liposome composition
JP2008255067A (en) * 2007-04-06 2008-10-23 Noevir Co Ltd Antioxidant
JP2009084243A (en) * 2007-10-02 2009-04-23 Pias Arise Kk Horny layer hyaluronic acid production accelerator and external dermatological preparation, cosmetic, and quasi-drug containing horny layer hyaluronic acid production accelerator
JP2009102228A (en) * 2007-10-19 2009-05-14 La Shinshia Kk Gel sheet and water-containing gel composition used for the gel sheet
JP2014518847A (en) * 2011-03-30 2014-08-07 ジーアール インテレクチュアル リザーブ リミティド ライアビリティ カンパニー Novel gold-platinum-based bimetallic nanocrystal suspension, its electrochemical production method, and use thereof
CN111419728A (en) * 2019-01-09 2020-07-17 戴红妹 High-efficiency nano spot-lightening, brightening and moisturizing activating agent and preparation method thereof
JP2020111567A (en) * 2019-01-09 2020-07-27 戴紅妹 Nano-activator having high effects for improving stains, whitening, and moisturizing and method for preparing the same
JP7486928B2 (en) 2019-08-09 2024-05-20 株式会社日本触媒 Aqueous dispersion for cosmetics, dispersion protecting agent, and method for producing cosmetics
CN111821314A (en) * 2020-03-25 2020-10-27 巫远程 Eye drops for treating myopia and cataract and its preparing process

Also Published As

Publication number Publication date
JPWO2006101106A1 (en) 2008-09-04
TW200704404A (en) 2007-02-01

Similar Documents

Publication Publication Date Title
WO2006101106A1 (en) Precious metal nanocolloid solution
Fu et al. Biomimetic CoO@ AuPt nanozyme responsive to multiple tumor microenvironmental clues for augmenting chemodynamic therapy
Jayaramudu et al. Chitosan capped copper oxide/copper nanoparticles encapsulated microbial resistant nanocomposite films
Pistone et al. Formulation of polysaccharide-based nanoparticles for local administration into the oral cavity
Teixeira et al. Photochemically-assisted synthesis of non-toxic and biocompatible gold nanoparticles
Putri et al. Highly antimicrobial activity of cerium oxide nanoparticles synthesized using Moringa oleifera leaf extract by a rapid green precipitation method
Muddineti et al. Xanthan gum stabilized PEGylated gold nanoparticles for improved delivery of curcumin in cancer
CN111467491A (en) Synthesis of platinum modified MOF2-Pt-FA as bidirectional enhanced photodynamic therapy medicine and application of platinum modified MOF2-Pt-FA in tumor therapy
Dhar et al. Gellan gum capped silver nanoparticle dispersions and hydrogels: cytotoxicity and in vitro diffusion studies
Zhao et al. Dual isolated bimetal single-atom catalysts for tumor ROS cycle and parallel catalytic therapy
CN108752395A (en) Stable iron oligosaccharide compound
Yan et al. Green synthesis of biocompatible carboxylic curdlan-capped gold nanoparticles and its interaction with protein
Qin et al. Green synthesis of biocompatible trypsin-conjugated Ag nanocomposite with antibacterial activity
Tao et al. Synthesis of pH‐responsive photocrosslinked hyaluronic acid‐based hydrogels for drug delivery
Saldías et al. In situ preparation of film and hydrogel bio-nanocomposites of chitosan/fluorescein-copper with catalytic activity
El-Sherbiny et al. New trimethyl chitosan-based composite nanoparticles as promising antibacterial agents
Hou et al. Full-active Cu2O/drug core/shell nanoparticles based on “grafting from” drug coordination polymerization combined with PD-1 blockade for efficient cancer therapy
Yang et al. Tirapazamine-loaded UiO-66/Cu for ultrasound-mediated promotion of chemodynamic therapy cascade hypoxia-activated anticancer therapy
Francis et al. Hydroxy propyl cellulose capped silver nanoparticles produced by simple dialysis process
JP2006282654A (en) Antioxidant
Moraes et al. Development of cashew gum-based bionanocomposite as a platform for electrochemical trials
Yan et al. H2O2 self-sufficient nanoplatform based on CeO2 QDs decorated MgO2 nanosheet for amplified chemodynamic therapy
Li et al. Facile synthesis of chondroitin sulfate-stabilized gold nanoparticles
Patel et al. A high yield, one-pot dialysis-based process for self-assembly of near infrared absorbing gold nanoparticles
Huang et al. Synthesis and testing of polymer grafted mesoporous silica as glucose-responsive insulin release drug delivery systems

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007509289

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06729617

Country of ref document: EP

Kind code of ref document: A1